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The peptide hormone leptin acts globally to maintain various metabolic processes. 
Impaired response to leptin binding is referred to as leptin resistance and results in 
metabolic dysregulation. Leptin is essential in the prevention of weight gain through 
central signals to increase energy expenditure and reduce food intake. A sugar 
sensitive pathway, the hexosamine biosynthesis pathway (HBP), may be the cause of 
diet induced leptin resistance. The HBP glycosylates proteins by modifying fructose-
6-phosphate molecules from glycolysis. While high sugar diets have been linked to 
leptin resistance, O-GlcNAcylation of pathway proteins have not been examined. 
Approximately 8-week-old male rats were assigned to ad libitum access to diet and 
water or 30% sucrose solution, diet and water. On Day 5 rats were surgically fitted 
with a third ventricle cannula. On Day 41, diet and sugar solutions were removed for 
an overnight fast. On Day 42 each rat received a central injection of leptin or control 
  
solution and subsequently euthanized 30 minutes post injection. Body weight and 
body composition were not significantly different between treatment groups after 42 
days. However, the Sucrose group exhibited signs of metabolic syndrome, evidenced 
by increased fasting serum triglycerides and glucose as well as decreased serum 
HDL. Analysis of hypothalamic O-GlcNAcylation revealed no significant difference 
between treatment groups. These data may be the result of variability of glucose 
utilization within the hypothalamus. These data support previous findings that 42-day 
access to a 30% sucrose solution yields evidence of metabolic syndrome in the 
absence of obesity as well as the absence of increased hypothalamic O-
GlcNAcylation. Future research should examine O-GlcNAcylation regionally within 
the hypothalamus. Analysis of protein specific O-GlcNAcylation was not achieved; 
however, a novel O-GlcNAcylation was observed in hypothalamic tissue at the 
Threonine 1808 residue of prolow-density lipoprotein receptor-related protein 1 
isoform X1 (LRP-1), a protein that may play a crucial role in leptin signaling. These 
data give further evidence to support the use of 30% sucrose solution to model leptin 
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Metabolic Syndrome (MetS) is a collection of defined metabolic abnormalities that include 
elevated markers including fasting triglycerides and fasting glucose as well as anthropometric 
measures such as waist circumference. Possessing three or more of the parameters used to define 
MetS has been shown to increase the risk of developing diseases like type 2 diabetes and 
cardiovascular disease. For example, the risk of developing type 2 diabetes is 5-fold higher and 
cardiovascular disease is 2-fold higher in MetS patients. (K. G. Alberti et al., 2009) Further, 
MetS patients are at a 3-4 fold increased risk of a myocardial infarction (MI) with a 2 fold 
increase in the likelihood of dying from the MI. (K. G. M. M. Alberti, Zimmet, & Shaw, 2005)  
Leptin, a hormone primarily secreted by adipocytes, circulates in concentrations that 
reflect adiposity. The greater the adiposity, the higher the leptin concentration in circulation. 
(Maffei M, 1995; Tobe K, 1999) Further, leptin acts both peripherally and centrally to regulate 
functions such as fat deposition and appetite, respectively. Leptin resistance, when tissues no 
longer respond to circulating leptin, causes hyperphagia, obesity and insulin resistance. 
Exogenous leptin treatment does not reverse leptin resistance, suggesting the leptin receptor or 
signal cascade has been disrupted. Leptin resistance phenotypes, obesity and insulin resistance, 
are diagnostic parameters for MetS.  Thus, understanding the cause of leptin resistance is a 
crucial step in preventing and reducing the risk to other diseases.  
Recent evidence suggests that a nutrient sensing pathway involving the posttranslational 
modification of proteins may be the molecular cause of leptin resistance. The Hexosamine 
Biosynthesis Pathway (HBP) uses glucose and glucosamine as substrates to produce the end 





protein modifying substrate. O-GlcNAcylation, resulting from the O-linked addition of UDP-
GlcNAc to serine and threonine residues, modifies protein activity primarily through influences 
on phosphoprotein interactions.  
High sugar diets can lead to leptin resistance without obesity, presumably by increasing 
glucose availability for the HBP. (R. B. Harris & Apolzan, 2015)  Glucosamine infusion can lead 
to leptin resistance without obesity, further suggesting the cause of leptin resistance may be 
related to nutrient flux through the HBP as glucosamine enters the pathway unregulated. 
(Vasselli, Scarpace, Harris, & Banks, 2013) Additionally, removal of high sucrose and high fat 
choice diets reverses diet induced leptin resistance in as little as 4 days, further linking nutrient 
availability to leptin resistance as a function of hexosamine signaling. (Apolzan & Harris, 2013) 
Leptin signaling is dependent on activation of two signaling pathways.  Signaling is 
activated in a Janus Kinase 2 (JAK2) -dependent and JAK2-independent manner. One major 
signaling pathway involves transducing leptin signaling through transcriptional regulation by 
signal transducer and activator of transcription (STAT) 3. Activation of STAT3 begins by 
phosphorylation of tyrosine 705 (Y705) residues and the subsequent dimerization between two 
phosphorylated STAT3 (pSTAT3) molecules.  However, selective inhibition of pSTAT3 at 
serine 727 (S727), a second STAT3 residue possibly essential to leptin signaling, reduced DNA 
binding of STAT3 even though pSTAT3 (Y705) were unchanged.(Gewinner et al., 2004) A 
second major signaling pathway, Phosphoinositide 3-Kinase (PI3K), regulates acute responses to 
leptin on feeding. (Hill et al., 2008)  While data suggests there is no contribution of PI3K 
signaling to the long-term effects of leptin on body weight, a distal target of PI3K signaling, 
forkhead box O1(FoxO1), may be an important component as FoxO1 promoter sites are adjacent 





Central but not peripheral leptin signaling is essential to preventing the phenotypes 
associated with leptin resistance. Specifically, leptin signaling in the arcuate nucleus (ARC) of 
the hypothalamus is a major target of circulating leptin as the ARC is rich with appetite 
modulating neurons.(Shutter JR, 1997) Furthermore, the two major neuronal populations in the 
ARC have opposing effects on appetite and are inversely regulated by STAT3 and FoxO1. 
Leptin induced PI3K signaling is responsible for regulating ion channels in both populations, 
inhibiting appetite stimulating neurons and increasing activity of appetite suppressing neurons 
(see Illustration 1). Transcriptional competition between STAT3 and FoxO1 is also present in 
both neuronal populations. Furthermore, the transcriptional activity of STAT3 and FoxO1 are 
opposing which leads to opposite effects on energy balance within the two neuronal populations. 
(Kitamura et al., 2006) STAT3 acts to reduce appetite by promoting anorexigenic signaling and 
inhibiting orexigenic signaling whereas the opposite is true for FoxO1. As a result, dysregulation 
of either STAT3 or FoxO1 could impair leptin signaling that ultimately results in impaired 
metabolism. 
Given the importance of STAT3 and FoxO1 signaling in the hypothalamus and the link 
between hexosamine biosynthesis pathway flux and leptin resistance, it’s important to consider 
the potential modification of these factors by hexosamine signaling. Indeed, high sucrose diets 
have been shown to increase O-linked N-acetylglucosamine (O-GlcNAc), the protein bound 
form of UDP-GlcNAc, in the hypothalamus of leptin resistant mice.(Zimmerman & Harris, 
2015). In the hypothalamus of the same animals, phosphorylation of pSTAT3 (S727) was 
decreased, even though STAT3 and pSTAT3 (Y705) concentrations were independent of leptin 
sensitivity. These data suggest O-GlcNAc may inhibit the phosphorylation of the S727 residue; 





liver tissue, a modification that did not reduce FoxO1 transcriptional activity. (Housley et al., 
2008) Together these data suggest O-GlcNAcylation may reduce STAT3 transcriptional activity 
and impair the inhibition of FoxO1 transcriptional activity.  Further analysis is required to 
definitively model these effects in relevant leptin resistant tissue rather than correlative data or 
data from another disease state.  
For this reason, we propose exploring O-GlcNAcylation of leptin signaling proteins in 
the hypothalamus of Sprague Dawley rats given long-term access to sucrose solution. Our first 
goal is to demonstrate the reproducibility of modeling diet induced leptin resistance using ad 
libitum access to a 30% sucrose solution. We then aim to analyze O-GlcNAcylation in the 
hypothalamus by quantifying total O-GlcNAc levels of the hypothalamus and examining 
phosphorylation of Protein Kinase B (AKT) at the serine 473 site as O-GlcNAcylation has been 
shown to reduce phosphorylation and as a result enzymatic activity of AKT. Further, FoxO1 is 
marked for degradation by phosphorylated AKT. Finally, we will attempt to analyze O-
GlcNAcylation of proteins in the hypothalamus using enzymatic tagging followed by copper 
click chemistry which biotinylates O-GlcNAcylated proteins. Biotinylation will allow for 
enrichment of O-GlcNAcylated proteins for mass spectrometric analysis, as the abundance of the 
post translational modification (PTM) is too low for analysis without enrichment.  
Hypothesis 1: Sprague-Dawley rats given ad libitum access to 30% (w/v) sucrose 
solution for 42 days will exhibit markers of metabolic syndrome without the presence of obesity.  
Hypothesis 2: O-GlcNAcylation of the hypothalamus will be increased in Sprague 
Dawley rats given 42 day ad libitum access to 30% (w/v) sucrose solution. 
Hypothesis 3: Novel O-GlcNAcylation sites will be observed in hypothalamus of 





Chapter 1: Literature Review 
Introduction to Leptin 
 Leptin is a hormone primarily secreted by adipocytes, though under certain conditions 
other tissues express leptin in small amounts. In contrast, leptin’s signal transducing receptor, 
ObRb, is ubiquitously expressed and is expressed in higher concentrations in non-adipocytes 
than adipocytes. The ubiquity of the ObRb receptor suggests leptin has pleiotropic effects. 
Indeed, leptin is known to play key roles in both energy balance and reproduction; thus, leptin 
and leptin receptor knockout results in obesity and infertility.  The role of leptin in energy 
balance is particularly interesting given that leptin expression increases with adiposity and 
central leptin is a potent suppressor of appetite. However, in obese subjects, plasma leptin 
concentrations are significantly higher than in lean subjects. These data suggest leptin resistance, 
a physiological state in which tissue no longer responds to endogenous or exogenous leptin, is a 
function of impaired receptor signaling or signal transduction. Leptin resistance leads to obesity 
and can lead to diabetes; as a consequence, understanding the molecular basis for leptin 
resistance is important in order to develop preventative measures and treatments. 
 
Leptin 
Leptin is a 16 kDa peptide hormone best known for its potent effect on energy 
homeostasis. The discovery of leptin and its crucial role in energy balance occurred well before 
the hormone itself was identified. Jackson Laboratories developed a strain of mice with an 
unknown genetic mutation that resulted in a hyperphagic, obese and sterile rodent, now known to 





surgical pairing of two animals’ circulatory systems, a wild-type mouse paired to an ob/ob 
mouse could restore normal food intake and body weight. This experiment clearly demonstrated 
the ob/ob phenotype was caused by the deletion of a circulating factor and with the incidence of 
obesity increasing researchers were particularly interested in discovering the deleted molecule. 
Once the advancement of positional cloning became available the ob gene and its product, leptin, 
were identified. Upon discovery, leptin was identified as a member of the cytokine family.  
Cytokines are small proteins that are expressed from one type of cell and have an effect on the 
behavior of another type of cell. Conforming to characteristics of cytokine family peptides, leptin 
is expressed by adipocytes and affects the behavior of many other cell types. As a result, leptin is 
often referred to as an adipokine.  
As an adipokine, factors that regulate adipose are often regulators of leptin expression, 
including food intake, insulin and corticosteroids to name a few.  CCAAT/Enhancer-Binding 
Protein a (C/EBPα) is a unique regulator of adipose tissue as it is expressed in high 
concentrations during adipocyte development and remains high throughout maturity. Upstream 
DNA of the ob gene contain sequences specific to C/EBPα binding. (Miller et al., 1996)  
C/EBPα significantly increases leptin gene expression in primary adipocytes. Through 
integrating pathways, insulin and corticosteroids modulate C/EBPα activity to regulate leptin 
expression. Other factors like adiposity and adipocyte size regulate leptin expression. The 
relationship of leptin expression and adiposity are important components in obesity research 
given leptin’s effect on satiety.		
Leptin has been referred to as a “satiety hormone” due to its potent effect on decreasing 
food intake and increasing energy expenditure, whether centrally or peripherally administered. 





serum leptin levels decrease while refeeding returns serum leptin levels. Interestingly, the 
decreases in leptin concentrations during fasting are greater than the decreases in body weight. 
Obese humans and rodents have high circulating leptin concentrations. (Maffei M, 1995)  High 
circulating leptin should cause hypophagia when in fact the opposite is observed. These data 
strongly support the theory that leptin related obesity is most likely a factor of signaling rather 
than expression. In fact, leptin receptor knockout mice or db/db mice are known to share a 
similar phenotype to ob/ob mice except db/db mice are diabetic, hence the abbreviation “db”. 	
 
Leptin Receptors 
Leptin receptor or ObR is present in six isoforms, ObRa- ObRf. Each isoform is created via 
alternative splicing.  As a consequence, domains are mostly homologous between the isoforms 
though functions are not. For example, the extracellular domains of the 6 isoforms are uniform. 
Apart from ObRe, transmembrane domains are uniform as well. However, of the six isoforms 
only one, ObRb, is known to transduce leptin signaling. Also known as the long form, ObRb, is 
the only isoform with a large intracellular domain capable of transducing leptin signaling (see 
Illustration 2).  
However, ObRb is not the only isoform relevant to leptin activity. ObRa and ObRc 
transport leptin across the blood brain barrier (BBB). The two receptors are saturated during 
leptin resistance and may contribute to obesity by reducing central leptin. However, saturation of 
ObRa and ObRc are not considered to be the sole cause of leptin resistance as central leptin 
administration is not sufficient to reestablish metabolic homeostasis. (R. B. Harris & Apolzan, 





leptin.(Ge, Huang, Pourbahrami, & Li, 2002) Together these receptors are responsible for the 
movement and signaling of leptin; but are not considered to be the cause of leptin resistance. 
 
Receptor Signaling 
Upon leptin binding to ObRb, the receptor dimerizes to initiate leptin signaling. JAK2 is 
constitutively bound to the intracellular domain of the receptor and is activated upon leptin 
binding. Additionally, JAK2 independent activation of the pathway occurs via the Src family of 
kinases.(Jiang, Li, & Rui, 2008) JAK2-dependent and independent pathways work in concert to 
activate target pathways. Neither deletion of JAK2 nor blocking Src kinases like c-Src or Fyn 
completely ablates leptin signaling. (Jiang et al., 2008)  
Leptin signaling is integrated into several pathways. STAT3 is the primary regulator of 
transcriptional activity by leptin. The JAK/STAT pathway is a basic pathway for cytokines. 
Phosphorylation of ObRb tyrosine1138 residue recruits STAT3 to bind to the receptor. Once 
recruited, JAK2 will phosphorylate STAT3 (Y705) residues, which activates STAT3 and 
promotes dimerization. Upon dimerization, STAT3 is translocated to the nucleus by the 
Importin-a-Importin-b1 heterodimer pathway, where STAT3 binds TTC/AT/CG/TGGAA 
sequence to regulate transcription. Among the factors regulated by STAT3, suppressors of 
cytokine signaling (SOCS)  3 transcription is upregulated by STAT3 as a negative feedback 
loop.  By binding tyrosine 985 residue on the leptin receptor, SOCS3 inhibits leptin signaling. 
While overexpression of SOCS3 can inhibit STAT3 activation, SOCS3 is unlikely to cause leptin 
resistance as SOCS3 expression has been shown to decrease in diet induced leptin resistance 





Central STAT3, specifically within the hypothalamus, regulates the expression of 
orexigenic and anorexigenic proteins. Pre-opiomelanocortin (POMC) is a strong inhibitor of food 
intake.(Yaswen L, 1999) Targeted ablation of POMC neurons leads to obesity and 
hyperphagia.(Xu, Kaelin, Morton, et al., 2005)  The expression of POMC is increased during 
leptin signaling, as STAT3 binds the promoter region to increase transcription. Further, leptin 
also acts to reduce orexigenic signals like Agouti Related Protein (AGRP) by transcriptional 
repression via STAT3 binding in the promoter region. STAT3 conditional knockout mice exhibit 
leptin resistance phenotypes like obesity, diabetes and infertility.(Gao Q, 2004) Thus, STAT3 
signaling plays an essential role in the effect of leptin on energy balance.  
STAT3 phosphorylation and subsequent dimerization occurs at the Y705 residue. This 
step is essential for STAT3 translocation and transcription in the nucleus. However, recent 
evidence has emerged that a second residue on STAT3, S727, may be a required component to 
STAT3 action. (Gewinner et al., 2004) As demonstrated in macrophages, leptin increases 
phosphorylation of Y705 and S727 residues of STAT3.  Inhibition of S727 phosphorylation 
significantly inhibits DNA binding by STAT3.(Gewinner et al., 2004) Furthermore, it is still 
unknown if phosphorylation of S727 is essential in all cell types. Interestingly, hypothalamic 
tissue and HepG2 cells show reduced phosphorylation of S727 but not Y705 during leptin 
resistance, suggesting the role of S727 in leptin signaling as well as leptin resistance. 
(Zimmerman & Harris, 2015) 
Some of the effects of leptin signaling are rapid; therefore, STAT3 cannot be solely 
responsible for the effect of leptin due to the time required for transcription. Another pathway, 
most likely involving phosphorylation, would be required to modify proteins rapidly to transduce 





acting on ion channels. (Hill et al., 2008) PI3K is a key component in the PI3K/AKT/MTOR 
pathway known to be responsive to hormones and growth factors. PI3K is activated upon leptin 
binding through the formation of a tertiary complex of JAK2, Small Heterodimer Partner (SHP)-
B and Insulin Receptor Substrate (IRS)-1 or IRS-2.(Duan, Li, & Rui, 2004) SHP-B binds JAK2 
at Tyrosine 813 to enhance JAK2 autophosphorylation.(Duan et al., 2004) While SHP-B is 
bound to JAK2, SHP-B binds and activates IRS-1 or IRS-2, the rate-limiting step for PI3K 
activation.  The p85 regulatory subunit of PI3K can then bind to the tertiary complex containing 
activated IRS1/2. Upon binding, conformational changes to the subunit activate the catalytic 
p110 subunit of PI3K. In turn PI3K activates target molecules like cation channels in POMC 
neurons to depolarize and increase firing rate.  
Interestingly, there appears to be no effect of PI3K signaling on the long-term effects of 
leptin. However, a distal target of PI3K signaling, FoxO1, does play a role in the effects of leptin 
signaling. FoxO1 is a transcription factor that regulates the transcription of many targets 
including POMC and AGRP. Furthermore, FoxO1 competes with STAT3 on POMC and AGRP 
promoter regions and acts to oppose STAT3. Under insulin and leptin signaling, FoxO1 is 
phosphorylated by PI3K target AKT to cause nuclear exclusion and degradation.  
 
Central vs. Peripheral Signaling 
Given the ubiquity of leptin receptor expression, leptin signaling is important in many 
tissues. However, the regulation of food intake and metabolism is controlled centrally. Peripheral 
knockouts of the leptin receptor exhibit normal energy balance and insulin sensitivity. (Guo et 
al., 2007) Clinically, peripheral leptin injections are used to treat lipodystrophy, a condition of 





ectopic fat deposition.  Increasing beta-oxidation via leptin administration is a common treatment 
for lipodystrophy. However, lipodystrophy is a disease of impaired leptin expression, rather than 
leptin signaling. As previously mentioned, leptin injections do not reverse leptin resistance, 
because leptin signaling is impaired. Therefore, exploring central tissues rather than peripheral 
tissues is pertinent to understanding leptin resistance. 
Leptin receptors are expressed throughout the brain, including the hindbrain and 
hypothalamus.(Tartaglia et al., 1995) All nuclei within the hypothalamus express ObRb. Leptin 
binding increases projections between hypothalamic nuclei. Hypothalamic control of energy 
balance is complex though it remains clear that the ARC is a major contributor of leptin’s effect 
on satiety. Located at the base of the hypothalamus, the ARC is rich with both POMC and AGRP 
neurons, both of which co-express ObRb. Leptin regulates POMC and AGRP neurons in two 
ways. First, leptin depolarizes both POMC and AGRP neurons in a PI3K dependent manner. 
AGRP depolarizes from leptin withdrawal where as POMC depolarizes from leptin addition. 
(Xu, Kaelin, Takeda, et al., 2005) Secondly, leptin regulates the expression of POMC and AGRP 
by promoter binding of STAT3 and FoxO1.(Kitamura et al., 2006) Deletion of ObRb in either or 
both neuronal populations of young rats results in hyperphagia, reduced energy expenditure and 
increased weight gain. Additionally, hyperinsulinemia occurs in the same knockout model and is 
partially restored upon unilateral ARC ObRb recovery.(Coppari et al., 2005) Further, the ARC 
projects to all other hypothalamic nuclei. Therefore, the ARC is a prime region for impaired 
leptin regulation.  
PI3K is essential to the acute effects of leptin signaling in both POMC and AGRP 
neurons. Leptin induced activation of PI3K phosphorylates mediators that increase the firing rate 





leptin induced reduction of FoxO1. (Kim et al., 2006) Phosphorylation of FoxO1 by AKT marks 
FoxO1 for degradation in the cytoplasm, a process known as nuclear exclusion. However, 
without phosphorylation, FoxO1 will remain in the nucleus to regulate transcription, specifically 
repressing POMC transcription and enhancing AGRP transcription to increase appetite (see 
Illustration 3). Furthermore, leptin signaling reduces the expression of FoxO1, while 
constitutively active FoxO1 inhibits the effect of leptin on food intake.(Kim et al., 2006) 
Furthermore, STAT3 competes with FoxO1 to increase POMC transcription and repress AGRP 
transcription. Coexpression of STAT3 and FoxO1 in AtT20 cells reduces FoxO1 induced AGRP 
promoter activity whereas the opposite effects were seen in POMC promoter activity. (Kitamura 
et al., 2006) Further, POMC and AGRP promoter regions contain adjacent binding sites for 
STAT3 and FoxO1 where the two transcription factors inhibit the others activity through 
transcriptional squelching. Given the effect of leptin on ARC AGRP and POMC expression as 
well as the regulatory effects of STAT3 and FoxO1 on those peptides, dysregulation between 
these two transcription factors in the ARC are potentially major players in leptin resistance. 
However, it remains unclear what causes the dysregulation of these factors, though diet induced 
leptin resistance suggests a potential pathway.   
 
 
Introduction to Hexosamine Pathways 
The HBP is designed to use nutrients to produce protein modifying O-linked 
hexosamines. O-GlcNAcylation is unique compared to other protein glycosylations, which are 
typically added to proteins to form long glycan chains and are often membrane associated. 





through the addition of a single modifier. Interestingly, the HBP has approximately 1,000 target 
proteins but only uses two enzymes to add and remove the glycosylate.  In contrast, 
phosphorylation requires several specific kinases and phosphatases to add and remove phosphate 
groups, respectively. While overall metabolism produces the ATP required for phosphorylation, 
the substrate for HBP is supplied by nutrient flux, specifically glucose. As a result, the HBP is 
strongly linked to disorders related to nutrient excess.  
 
Hexosamine Biosynthesis Pathway 
HBP is a nutrient-sensing pathway used to monitor nutrient excess of lipids, sugars and 
glucosamine.  Free fatty acids, glucose or glucosamine flux increases HBP activity.(Cooksey & 
McClain, 2011; Marshall S, 1991)  The pathway senses nutrient excess by integrating with 
glycolysis. As with all pathways there are regulatory measures to supply substrate to the relevant 
pathway as well as feedback mechanisms to slow substrate conversion when product 
concentrations become too high. Typically, HBP will utilize about 1-3% of glucose to produce 
the end product UDP-GlcNAc.(Marshall S, 1991) Under conditions in which cellular glucose 
concentrations are increased, the pathway will use even more. Furthermore, high free fatty acid 
concentrations increase Acetyl-CoA, which increases activity of the TCA cycle, in turn reducing 
glycolysis. As a result, more glucose is available to shuttle into the pathway. For these reasons, 
HBP is considered a nutrient sensing pathway and a target for disorders of metabolism.  
UDP-GlcNAc is formed through a series of enzymatic reactions involving glucose or 
glucosamine. The two substrates share similar pathways except glucosamine enters the pathway 
later, bypassing the rate-limiting step. When glucose enters the cell the conversion to glucose-6-





donor. Next, G6P is converted into fructose-6-phosphate (F6P), the integrating point between 
glycolysis and the biosynthesis pathway. As previously mentioned, the pathway uses 1-3% of 
F6P but more can be used depending on nutrient status. F6P is catalyzed by the rate limiting 
enzyme glutamine: fructose-6-phosphate amidotransferase (GFAT) into glucosamine-6-
phosphate (GlcN-6-P) (see Illustration 4). The product of GFAT catalysis is joined by available 
glucosamine and quickly converted to the end product, UDP-GlcNAc. The high-energy substrate 
UDP-GlcNAc then covalently modifies proteins.  
 
Protein Modification Through Hexosamine Biosynthesis Pathway 
The HBP uses UDP-GlcNAc and two enzymes to catalyze the removal and addition of O-
GlcNAcylates to residues. O-linked N-acetylglucosamine transferase (OGT) is responsible for 
catalyzing the addition of O-GlcNAc to proteins. Similarly, only B-D-N acetylglucosamine 
(OGA) is responsible for the removal of O-GlcNAc. Since there are only two enzymes involved 
in O-GlcNAc signaling there must be a mechanism to allow for the dynamic action of O-
GlcNAcylation. Indeed, one such mechanism is that variant isoforms of each enzyme act in 
different locations or on different systems. OGT and OGA both exist in variable isoforms; 3 
splice variants for OGT and 2 splice variants for OGA (see Illustration 5). N-Terminal repeats 
differentiate the structure of the OGT isoforms as well as their locations and action. Two 
isoforms, mOGT and sOGT, are associated with apoptosis, whereas ncOGT is present in the 
cytoplasm and nucleus, and acts as the major enzyme for O-GlcNAcylation. The OGA isoforms 
vary by structure and location. Long OGA (OGA-L) contains a pseudo HAT domain at the c 
terminus, whereas short OGA (OGA-S) does not have the extra C-terminal domain and is 





made evident by OGA-L expression reverses O-GlcNAcylation by 72% where as OGA-S 
reversed O-GlcNAcylation by only 35%. (Keembiyehetty, Krzeslak, Love, & Hanover, 2011) 
HBP is a seemingly simple regulatory mechanism given it has only three components for 
signaling, whereas phosphorylation has numerous kinases and phosphatases that work 
specifically within their respective pathway. HBP uses only UDP-GlcNAc, OGA and OGT to 
regulate the same pathways regulated by phosphorylation. An additional layer of complexity to 
hexosamine signaling is the competition between O-GlcNAcylates and phosphates, which is 
divided into 3 categories. First, both posttranslational modifications can bind serine and 
threonine residues; therefore, O-GlcNAc can compete with phosphates to bind a specific residue. 
Secondly, the modifiers can compete for steric hindrance. As a result, the binding of one 
modifier creates steric hindrance to prevent the binding of the other at an adjacent site. Finally, 
both modifiers can simultaneously bind to a protein but the effect of one of the two modifiers 
will predominate. For example, a phosphorylated protein can become O-GlcNAcylated at which 
point the phosphoprotein activity will reduce while the effect of the glycosylates will take 
precedence.  
Nearly one thousand proteins have been identified as being GlcNAcylated; including 
proteins of cytoskeletal networks, stress responses and transcriptional regulators. Furthermore, 
potential contributors to leptin resistance, STAT3 and FoxO1, are included in O-GlcNAc targets. 
In fact, O-GlcNAcylation of several STAT proteins was previously demonstrated in HC11 
mammary epithelial cells. (Gewinner et al., 2004) In HC11 cells STAT3 was identified as a 
target of O-GlcNAcylation through hormonal stimulation. However, the only STAT protein 
thoroughly examined was STAT5. Specific data regarding target residues is unknown as well as 





characterized through the use of several liver cell culture models. In addition to being O-
GlcNAcylated at several sites, FoxO1 O-GlcNAcylation and phosphorylation do not inhibit the 
occurrence of one another. (Housley et al., 2008)  O-GlcNAcylation increases FoxO1 DNA 
binding in FAO hepatoma cells to increase expression of gluconeogenic and stress related genes. 
(Housley et al., 2008)  Insulin signaling or mutation of threonine 317 (T317) inhibits the effects 
of O-GlcNAcylation on FoxO1. The dynamics of O-GlcNAcylation in hypothalamic tissue needs 
to be established, as the ARC is the major target of leptin dysregulation. However, current 
knowledge of both STAT3 and FoxO1 O-GlcNAcylation in non-hypothalamic tissues shows 




Diet Induced Leptin Resistance 
Leptin resistance is achieved through dietary interventions like high fat, high sugar and choice 
diets. Sprague Dawley rats given ad libitum access to a choice diet of chow, lard and 30% 
sucrose solution causes peripheral and central leptin resistance by day 16. (Apolzan & Harris, 
2013) Removal of choice diet returns peripheral and central leptin sensitivity within 4 days. 
(Apolzan & Harris, 2013) These data suggest leptin resistance is sensitive to nutrient flux, which 
further supports the theory that O-GlcNAcylation of leptin signaling molecules impairs leptin 
signal transduction.  High fat diets and high sucrose diets have been shown to cause leptin 






Detecting O-GlcNAcylation  
 O-GlcNAcylation is a PTM to proteins, which requires mass spectrometry techniques 
conducive to identifying proteins as well as site modifications. Two important factors in 
identifying PTMs are enriching for the modifier of interest and analyzing the sample using 
tandem mass spectrometry.  
Enzymatic tagging and copper click chemistry facilitate enrichment of O-GlcNAcylated 
proteins. Copper click chemistry facilitates the reaction between highly reactive azides and 
alkynes. Azides are added to O-GlcNAcylated proteins through the enzymatic addition of azide 
containing sugar GalNAz. Once azide groups are added present the click reaction can take place 
through the addition of the chosen tag containing an alkyne group. Copper catalysts like CuSO4 
are used along with reducing agents like sodium ascorbate to catalyze the cyclic reaction. 
Additionally, polyligands like THPTA are added to accelerate the reaction. Selecting a tag that 
can be enriched with affinity columns, primarily biotin conjugates, allow the researcher to select 
for the modification and remove unmodified proteins from a complex sample. Once enriched, 
mass spectrometric analysis of PTMs are analyzed using tandem mass spectrometry. 
Collisionally induced dissociation (CID) and electron transfer dissociation (ETD) are used in 















All animals were given ad libitum access to their respective treatment diets. A standard 
diet was provided to all treatment groups. The diet was a nutritionally complete blend [Teklad 
Global 18% Protein Rodent Diet] prepared by Envigo (Madison, WI) containing 3.1 kcal/g of 
diet (see Table 1). All rodents were provided with ad libitum access to water, while the sucrose 
group were also given ad libitum access to a 30% (w/v) sucrose solution. A 30% sucrose solution 
was used because a large body of data has demonstrated a 30% sucrose solution consistently 
induces leptin resistance as well as being the preferred model for diet induced obesities 
compared to other sugars, modes of delivery and percent solute.(Apolzan & Harris, 2012, 2013; 
R. B. Harris & Apolzan, 2012, 2015; London et al., 2007) Access to a sucrose solution results in 
a displacement of diet intake of approximately 60%, which helps mirror the increase of dietary 
sugar intake in humans. (Castonguay, Hirsch, & Collier, 1981; London & Castonguay, 2009) 
Further, the use of sucrose is theorized to best model human consumption of dietary sugars as the 
composition of dietary sugars are rarely pure glucose or fructose.  
Animal Model 
Adult male Sprague Dawley (CD strain) rats (Charles River Laboratories, Wilmington, 
MA) weighing approximately 300 g were used. All animals were individually housed under a 





were given a 3-day acclimation period of ad libitum access to diet and water. On Day 1, animals 
were randomly assigned to two dietary treatment groups, Sucrose or Control.  Rats assigned to 
the Sucrose group were given ad libitum access to sucrose solution, water and diet; rats assigned 
to the Control group were given ad libitum access to water and diet only. On Day 5, each rat was 
fitted with a lateral ventricle cannula via stereotaxic placement. On Day 7, cannula placement 
was tested using an angiotensin II (150 ng/5 ul) challenge.(Bellinger, 1997) On Day 41, food was 
removed at the start of the light cycle for an overnight fast. On Day 42, each rat was lightly 
anesthetized using Isoflurane and was then administered an intracerebroventricular (ICV) 
injection of either leptin (1.5 ug/2 ul) or saline (2 ul). This protocol timeline is represented in 
Illustration 6. Each rat was sacrificed 30 minutes post injection. All methods were approved for 
use by the Panel on Euthanasia of the American Veterinary Medical Association as well as the 
University of Maryland Institutional Animal Care and Use Committee (approved protocol # R-
16-01). All procedures described herein are in compliance with and were approved by the 
University of Maryland’s Animal Care and Use Committee guidelines. 
 
Surgery 
Rats were anesthetized via intraperitoneal injection of ketamine (100 mg/kg) xylazine (10 
mg/kg) cocktail (0.2 ml/100 g). Once an animal lost motor control, the surgical site was prepped, 
and the rat was placed in the stereotaxic. The coordinates for placement of the cannula were 
lateral – 1.4 mm, AP -0.8 mm and ventral -3.3mm of bregma, using the Watson and Paxinos Rat 
Brain Atlas. The cannula was fixed into place using dental acrylic and post-surgical recovery 
was aided with a subcutaneous injection of saline immediately post-op and a subcutaneous 






Sacrifice and Tissue Collection 
Post injection on Day 42, each rat was returned to its cage for 30 minutes before sacrifice 
using a CO2 O2 exchange chamber. Immediately after noting its time of death each rat was 
decapitated and truncal blood was collected. Serum samples were collected from truncal blood 
after clotting and centrifugation at 1,400 x g at 4°C for 15 minutes. Collected serum was stored 
at -80°C. Brain and liver were dissected and flash frozen in dry ice chilled isopentane then stored 
at -80°C. Carcasses were collected and stored at -20°C. Brains were later thawed to -15°C for 




Rat carcasses were thawed and total body composition of each was measured using an 
EchoMRI-900 quantitative NMR analyzer (Echo Medical Systems, Houston, TX). Output 
included measurement of fat mass and lean tissue mass. 
Leptin and Insulin 
Serum leptin and insulin concentrations were determined using the Mouse/Rat Insulin 
Leptin Multiplex kit (Meso Scale Discovery #K15158C; Rockville, MD) from sera of Sprague 





Glucose and Lipid Profiling 
Plasma glucose concentrations were measured enzymatically (Smith-Kline Beecham 
Laboratories, Brentford, London). A 36 Dimension clinical chemistry system Flex reagent 
cartridge (Siemens Healthcare Diagnostics, Newark, DE) was used with a Dade Behring 
Dimension Xpand automated system to quantify plasma triglyceride. Profiling of lipids and 
glucose was performed using a Vitros Clinical Analyzer to measure glucose, HDL, LDL, 
cholesterol and triglycerides. 
 
Protein Extraction and Digestion 
Protein extracts from left hypothalamic tissue were obtained using a modified method of   
Ma and Hart (2016). Briefly, tissue extract was weighed and lysis buffer (Tris-HCl pH 7.5, NaCl, 
Triton-X, NaF, β-Glycerophosphate, PUGNAc, 1 x Halt Protease Inhibitor Cocktail) was added. 
Tissue was homogenized by passing sample through 18 gauge needle and subsequently sonicated 
twice for 10 seconds with 10 second rest in between. Samples were then incubated on ice for 30 
minutes with vortexing every 5 minutes. Finally, samples were centrifuged at 10,400 x g for 10 
minutes at 4°C. The supernatant was collected, protein quantification was analyzed via BCA 
quantitation (Pierce™ BCA Cat# 23225; Waltham, MA). Lysate was separated into aliquots and 
stored at -80°C. 
 
O-GlcNAc Quantitation 
Total hypothalamic O-GlcNAc was quantified using the Simple Wes system by 
ProteinSimple™ (San Jose, CA). Briefly, hypothalamic lysate was diluted to 0.7 ug/ul with 





Technology, Danvers, MA) was diluted 1:75 in Antibody Diluent 2 provided in ProteinSimple™ 
Mouse Diluent pack . Samples and reagents were loaded in duplicate onto 25 capillary plates. 
Plates were run using Simple Wes Total Protein protocol for all parameters including separation 
time, incubation times and washes. Samples were normalized to total protein in the same run by 
applying the adjusted total protein factor to the total chemiluminescence from the O-GlcNAc 
capillaries of corresponding samples. Between plate normalization was adjusted by applying 




Due to difficulties arising during surgery or post-surgery, some animals had incomplete 
data sets. To keep sample sizes as large as possible incomplete data sets were not immediately 
omitted; sample sizes are noted for all analyses. Further, rats were compared by Sucrose fed and 
Control fed treatments only as cannula placement could not be accurately verified. For data 
related to injection (leptin vs saline) please refer to the Appendix for cannula verification data 
via angiotensin II and pSTAT3 (Y705), hypothalamic protein analyses and enrichment of O-
GlcNAcylation data. 
 Statistical assumptions were met for all analyses and were analyzed using the general 
linear model (GLM) for normality of the residuals and the Levene’s test for homogeneity of the 
variances. Body weight and composition (Control n=26, Sucrose n=21) were analyzed using the 
GLM (SAS, Cary, N.C.), as this model best handles unbalanced data. Analysis for repeated 





GlcNAC blot (Control n=16 Sucrose n=16) were analyzed using a two sample t-test. 
Correlations were analyzed using the same experimental units for analyzing circulating factors. 
Pearson’s correlation coefficients were calculated to determine if x and y factor were 
significantly correlated in all samples (n=32) or by treatment group (n=16). Comparison of 
Control vs Sucrose groups correlations were performed using Fisher’s z transformation of the 
Pearson correlation coefficient and defined variance of 1/ (n1-3) + 1/ (n2-3), where n1 and n2 are 





Chapter 3: Results 
 
Body Composition  
Neither body weight nor body composition differed significantly between feeding groups 
during the 6-week treatment period. Body weights taken at the start of the dietary treatment were 
not different between treatment groups (see Table 2). Mean final body weights that were 
measured on Day 42 did not differ between treatment groups.  The changes in body weight from 
Day 1 to Day 42 were not different.  Mean weight gain over the 42-day experiment was 178 g 
(+/- 7.2 SEM) in Control fed rats vs 182.7 g (+/- 9.6 SEM) change in Sucrose fed rats (p-value= 
0.6891). However, there was a significant effect of time on body weight during the 6-week 
feeding period (see Figure 1).  Further analysis showed no group differences in body weight 
measurements at any time during the 6-week period.  
On Day 41 chow and sucrose solutions were removed from cages for a 12 hour overnight 
fast. The difference in body weight was measured between day 41 and day 42. The data show no 
difference in weight loss between these two days. Control fed rats lost an average of 2.3 g (+/-1.7 
SEM) whereas the Sucrose fed group lost an average of 4.6 g (+/-2.0 SEM) (see Figure 2). Body 
composition analysis showed little difference between treatment groups as well. Both groups on 
average had approximately 20% fat mass (see Table 1). To analyze the effect of diet on body 
composition, a ratio was used of fat to lean mass (FTL ratio). The difference between FTL ratios 
was not significant between Sucrose and Control fed animals (see Figure 3). Together these data 
suggest that 42-day ad libitum access to a 30% sucrose solution did not significantly affect 







Circulating factor profiling  
While body composition showed little differences between treatment groups, several 
circulating factors that are hallmarks of metabolic syndrome were found. In particular, the lipid 
profile of sucrose fed rats revealed that serum triglycerides were significantly higher when 
compared to controls (p=0.002) (see Figure 4). Further, serum HDL cholesterol was significantly 
(p=0.0278) lower by approximately 14% in sucrose fed vs control fed rats. Interestingly, serum 
cholesterol and LDL of sucrose fed rats did not differ significantly from that of controls.  
Despite the lack of difference in body fat composition, circulating leptin was significantly 
higher in sucrose fed animals vs control fed animals (p=0.0362) (see Figure 5a). Finally, plasma 
insulin and glucose profiling revealed no significant difference in serum insulin between 
treatment groups (p=0.9451) but revealed significantly increased serum glucose in sucrose fed 
animals compared to control fed animals (p=0.0207) (see Figure 5).  
Correlating metabolic data 
The correlations between metabolic factors (like body composition) and circulating 
factors were statistically evaluated.  The FTL ratio was positively correlated with both serum 
triglyceride levels and leptin levels despite the lack of treatment effect on body composition as 
previously discussed (see Figure 6). Further, cholesterol and HDL were strongly and positively 
correlated with one another. However, the effect of diet on HDL dampened the correlation, 
resulting in a reduced correlation between the two in sucrose fed animals (see Figure 7). 
Similarly, HDL and glucose were significantly and positively correlated in sucrose fed rats 
(r=0.636) but not control fed rats (r=0.097). While the differences between groups approached 





not significantly different (see Figure 8).  Finally, a moderately positive correlation between 
triglycerides and glucose was found in the control group (see Figure 9).  
Global O-GlcNAcylation of Hypothalamus 
Sucrose access results in increased activity in the hexosamine biosynthesis pathway by providing 
the pathway more substrate. Total O-GlcNAc chemiluminescence signal was averaged between 
replicates and normalized to a factor based on total protein chemiluminescence. The data was 
then normalized between blots using a factor between membranes. Contrary to our expectations, 
there was no significant difference in total hypothalamic O-GlcNAcylation between treatment 
















Chapter 4: Discussion 
 
Diet Induced Metabolic Dysregulation 
Body Composition 
  Our dietary treatment is modeled from Harris and Apolzan (2015), where they reported 
that body weights were not significantly different after 44 days between rats given a control 
chow diet and sucrose fed rats given ad libitum access to a 30% sucrose solution and chow. Our 
results replicate the Harris findings, showing no significant difference in body weight after 42 
days of ad libitum access to 30% sucrose solution compared to control. Other investigators have 
reported that sucrose solutions can induce significant weight differences in as little as two 
weeks.(Castonguay et al., 1981; Lindqvist, Baelemans, & Erlanson-Albertsson, 2008; Rattigan & 
Clark, 1984) However, those experiments may have been influenced by other factors like 
species, composition of chow, age and social housing. A previous study in our laboratory 
revealed no significant difference in body weight of male rats fed 16% or 32% sucrose solution 
when compared to controls for 72 days.(London et al., 2007) Our model has consistently 
demonstrated that long term access, greater than 72 days, to sucrose solution is required to see 
significant differences in body weight.(Apolzan & Harris, 2012; R. B. S. Harris, 2018; Kanarek 
& Orthen Gambill, 1982; Zimmerman & Harris, 2015) 
Contrary to our observations that no differences in body composition at day 42 were 
statistically significant, Harris reported that at Day 44 the sucrose fed rats had increased body fat. 
We believe that these differences are a function of method rather than differing results. 





both subcutaneous and visceral. Harris’ method of dissecting fat pads measures only distinct 
collections of fat and fails to include an accurate estimate of subcutaneous fat. Echo MRI 
replicates the body composition methods most like what human subjects and patients would 
undergo to determine excess adiposity, such as dual-energy X-ray absorptiometry as well as 
displacement of air or water.  This includes developing an estimate for subcutaneous fat.  Note 
that our findings do not suggest that Harris et al were in error. Fat pad analysis can be used to 
more effectively estimate increases in harmful depots like visceral adipose tissue. As a major 
contributor to metabolism, adipose tissue plays an essential role in preventing metabolic diseases 
such as insulin resistance. However, not all adipose tissue is metabolically equivalent. 
Subcutaneous and visceral adipose tissue are believed to have opposite influences on the risk of 
developing insulin resistance. Removal of visceral adipose tissue as well as transplanting 
subcutaneous adipose tissue into visceral depots have been shown to improve insulin 
sensitivity.(Barzilai et al., 1999; Cox-York, Wei, Wang, Pagliassotti, & Foster, 2015; Foster et 
al., 2013) For a more thorough review of adipose depot comparisons please refer to Bjorndal et. 
Al. 2011. 
Initially we had predicted that fasting weight loss (performed after 42 days of access to 
sucrose) would be stunted in sucrose fed rats due to the reduction in metabolic rate that 
accompanies leptin resistance.  However, fasting weight loss was not significantly different 
between treatment groups. Fasted weight loss can be used to measure differences in metabolic 
rate when more sophisticated equipment is not available. (Rixon & Stevenson, 1956) However, 
the goal of the overnight fast was to sacrifice the animals in a fasted metabolic state rather in 
than estimate metabolic rate. What is more, the procedure that we used was not designed for such 





period, thereby increasing variability. Interestingly, during the light cycle, when rats are mostly 
dormant but still regularly consume calories, caloric intake is not different between control and 
sugar fed rats. (Castonguay et al., 1981) Rather, it is likely that the observed differences in intake 
occurred during the dark cycle. A more accurate protocol would better capture fasted weight loss 
without the variability of intake and may have captured any differences in metabolic rates.  
 
Sucrose Solution Promotes Metabolic Syndrome 
 
Three of the diagnostic parameters for MetS were observed in the fasting serum of our 
sucrose fed rats, despite no differences in body weight. Firstly, we observed an increase in serum 
glucose of sucrose fed rats compared to their controls. The increase in circulating glucose is 
potentially a result of the body’s inability to properly metabolize the high supply of sugar from 
the diet. Rats will consume ~60% of their total daily calories from a sucrose solution. 
(Castonguay et al., 1981; London et al., 2007) Hyperglycemia can be attributed to different 
etiologies depending on the conditions. Our data suggests that impaired glucose uptake could be 
an indication of insulin resistance. Further, we failed to observe hyperinsulinemia despite 
increased glucose levels in circulation; this pattern is associated with a later stage of insulin 
resistance in which insulin secretions cannot keep up with the demand and are no longer 
elevated. The result of excess glucose, as well as fructose, is indirect stimulation of de novo 
lipogenesis (DNL), a process in which sugar is converted into triglycerides.(McDevitt et al., 
2001) Due to the lack of regulatory steps in fructose metabolism, intake of fructose solution has 
been shown to induce hypertriglyceridemia in as little as 24 hours.(Colley & Castonguay, 2015) 
Lipids are produced in the liver as well as adipocytes as a means to store excess energy in the 





triglycerides of sucrose fed rats were almost doubled that of the control counterparts. It should 
also be noted that, serum HDL levels were reduced in sucrose fed rats. This decrease in HDL is 
most likely a function of the downregulation of ATP-binding cassette transporter (ABC) A1 and 
apolipoprotein (apo) AI by excess glucose in the diet.(Hussein et al., 2015) Together these data 
have allowed us to suggest that sucrose access initiates a cyclical disruption in metabolism that 
can lead to MetS associated diseases. To start, HDL has been shown to regulate glucose 
metabolism by increasing insulin secretion, glucose uptake and tissue utilization.(Drew, Rye, 
Duffy, Barter, & Kingwell, 2012) However, this overabundance of glucose reduces HDL 
production thereby impairing glucose usage to some degree. The impaired utilization of glucose 
as well as dietary fructose results in increased triglycerides as a means to deal with the excess 
substrate. Under acute conditions these effects are not pathogenic, as adipose tissue is designed 
to store fat. However, combined with the loss of leptin sensitivity (as evidenced by high leptin 
concentrations), lipids are deposited into non-adipocyte tissue such as liver and pancreas. These 
tissues are insufficient to store excess lipids found in circulation. As a result, glucose uptake is 
further impaired leading to increases in circulating glucose which continues to supply the cycle.  
Changes in metabolism due to diet can be observed by examining the correlations 
between factors like serum markers with anthropometric measurements.  An important factor in 
the development of cardiovascular disease is a disruption in the balance of lipids (such as 
cholesterol) and transport molecules (such as HDL). An analysis of our data revealed that serum 
cholesterol is positively correlated with serum HDL, as seen in Figure 8. As the lipoprotein 
responsible for reverse cholesterol transport, HDL is important in the removal of damaging 
cholesterol concentrations from tissue. As a consequence, a strong positive correlation is 





sucrose fed rats. We believe that the difference between treatment groups is due to the reduction 
in HDL without a concomitant reduction in cholesterol in sucrose fed rats. When determining 
risk for cardiovascular disease, HDL levels must be considered in conjunction with cholesterol 
levels as high cholesterol levels are not always harmful if HDL levels are proportionately 
increased.(Taskinen et al., 2010) As previously mentioned, HDL and glucose have been shown 
to regulate one another.(Drew et al., 2012; Hussein et al., 2015) However, HDL is not correlated 
with glucose in control fed rats. Interestingly, we observed a strong correlation between the two 
amongst the sucrose fed rats (a correlation coefficient of 0.636). Both HDL and glucose have 
been shown to downregulate one another; thus, the correlation we would expect to be negative. 
On average, serum glucose levels increased, and serum HDL levels decreased in sucrose fed rats. 
This unexpected directionality of the correlate may be due to the limited down regulation of 
HDL by glucose, which under acute conditions the negative correlation may be observed. 
However, because the glucose concentrations continue to rise under the feeding conditions the 
correlation becomes positive. A similar response was observed in the correlation of glucose with 
triglycerides. Under control conditions the two factors are positively correlated. However, the 
correlation drops to near zero in sucrose fed rats despite triglycerides and glucose increasing on 
average as seen in Figure 9. The changes in these relationships suggest that glucose no longer 
proportionately increases triglycerides.  Rather, the glucose levels suggest a phenomenon known 
as selective insulin resistance. Under these conditions liver tissue is insulin resistant which 
prevents insulin from downregulating gluconeogenic proteins. However, insulin sensitivity to 
insulin induced lipogenesis is maintained.(Shimomura et al., 2000)  As a result, the liver 
contributes to both hyperglycemia and hyperlipidemia. This paradox is best illustrated by Brown 





normal liver, in which insulin can phosphorylate FoxO1 to inhibit gluconeogenesis as well as 
increase triglycerides through the upregulation of sterol regulatory element-binding protein 
(Srebp) -1c. As a result, circulating glucose and triglycerides are taken up by tissue 
appropriately. The second model is type 2 diabetes in which the liver is selectively insulin 
resistant. Under these conditions, insulin cannot inhibit gluconeogenesis in the liver due to 
insulin resistance in the liver as well as other tissue. As a result, insulin upregulates lipogenesis 
in addition to rising glucose levels. The final model, which supports the theory of selective 
insulin resistance uses a liver-specific insulin receptor knockout (LIRKO) model in which the 
liver is completely insulin resistant. As a result, gluconeogenesis is increased without increased 
triglycerides. Our model deviates from selective insulin resistant model in that our rodents were 
not hyperinsulinemic; however, the disproportion of glucose to insulin suggests impaired insulin 
output, a sign of insulin resistance. Further, the insulin that is present in our sucrose fed rats 
would still be unable to downregulate gluconeogenesis leading to the simultaneous increase in 
glucose and triglycerides.  
Body composition is only a small piece of metabolic dysregulation of diet induced 
obesities. Changes in circulating factors in combination with composition data better characterize 
the changes high sugar diets can induce. For example, leptin circulates in concentrations 
reflecting adiposity. Leptin is positively correlated with FTL (fat mass:lean mass) ratios, the 
larger the ratio the higher adiposity, However, we observed  no significant differences in  FTL 
ratios between treatment groups. Further, triglycerides are positively correlated with FTL ratio. 
These data suggest the likelihood that body composition is actually different between treatment 





adiposity. Collectively, these data demonstrate the promotion of MetS in rats given ad libitum 
access to a 30 % sucrose solution for 42 days. 
 
 
Diet Induced O-GlcNAc Protein Modifications 
We failed to find a significant increase in protein O-GlcNAcylation in the hypothalamus 
of sucrose fed rats. Analysis of O-GlcNAcylation in the hypothalamus is fairly new. Previously, 
mice given 44 day access to 30% sucrose solution had increased O-GlcNAcylation in the 
hypothalamus. However, a similar study design, using rats, (by the same research group) showed 
no significant difference in hypothalamic O-GlcNAc. While it is certain that the hypothalamus 
overall regulates energy balance, within the hypothalamus are specific nuclei that differentially 
contribute to energy balance. We believe that different nuclei respond to glucose increases 
differently. For example, AGRP neurons of the arcuate nucleus have higher O-GlcNAc 
concentrations during fasted versus fed states.(Y. Liu et al., 2012) The increase in O-GlcNAc 
observed in mice that was not observed in rats may be a result of more robust increases and 
minimal decreases in O-GlcNAc throughout the hypothalamus generating an overall increase. 
Further analysis is required to characterize O-GlcNAcylation in the hypothalamus under control 
and sucrose stimulated conditions.  
 
Future Directions 
Hypothalamic Nuclei Specific Changes 
As noted above, future investigations into diet induced O-GlcNAc modifications should 





experiments would not only give insight to diet induced changes in specific regions of the 
hypothalamus but would also generate data regarding uptake of nutrients by the specific regions 
as increases in O-GlcNAc require glucose or glucosamine. To analyze hypothalamic O-GlcNAc 
on a nuclei specific basis, pooling would be required between samples in order to have enough 
material. Further, each region would have to be verified by site specific expression of mRNA or 
protein to avoid sampling from adjacent nuclei. A previous report using a punch technique for 
sampling hypothalamus examined 3 nuclei for site specific expression.(Zhao, 2015) As a result, 
apart from growth hormone, no expression levels were undetectable but varied expression 
patterns could aid in site verification. The three regions examined were the paraventricular 
nucleus (PVN), ventromedial hypothalamus (VMH) and the lateral hypothalamus (LH). 
Expression of 4 factors were robust in the PVN compared to the VMH and LH. The VMH 
expressed high levels of AGRP while the expression of growth hormone in the PVN was 
undetectable. Therefore, the VMH can be identified by AGRP expression and the LH can be 
identified by growth hormone expression in conjunction with low AGRP expression. These 
regions maintain energy balance as a whole but contribute to energy balance in different ways. 
The VMH and PVN are believed to be satiety centers as their ablation leads to obesity; the 
opposite is true of the LH. Previously, O-GlcNAcylation was shown to be increased in fasted 
AGRP neurons of the ARC.(Y. Liu et al., 2012) Knockout models of AGRP exhibit significant 
weight reduction as AGRP is an orexigenic signal. The most interesting region to examine would 
be the VMH given its high expression of AGRP and opposing contribution to energy balance. 
These data would demonstrate patterns of O-GlcNAcylation as being neuronally specific or 





Silent Destruction of Metabolism 
The results outlined in this dissertation add to the body of work that identifies high 
sucrose diets as a means to promote MetS in rats.  One of the most important observations noted 
here is the lack of anthropometric evidence of metabolic syndrome. We believe that under 
dietary challenges like high sucrose diets, the damage that results from metabolic syndrome is 
already occurring long before there is gross visual evidence of a change in body composition.  
Regardless, the reversibility of these changes has not been well established.  Leptin resistance 
induced by 16 days of choice diet can be reversed with 4 days of chow diet.(Apolzan & Harris, 
2013) Further, complete reversal of hypothalamic pSTAT3 (Y705) response was not achieved 
after 45 day access to 30% sucrose solution in rats.(R. B. S. Harris, 2018) The point at which 
sucrose induced leptin resistance is no longer reversible remains unknown as does the 
contribution of obesity to the reversibility of sucrose induced leptin resistance. These data could 
be important in understanding the timeline of diet induced metabolic syndrome in terms of 




 The goal of our project was to replicate previous work demonstrating the ability of 
sucrose solutions to induce leptin resistance while further analyzing the contribution of sucrose 
solutions to leptin resistance. Indeed, our data support the use of 30% sucrose solution as a 
means to model metabolic syndrome, though our achievement of leptin resistance is speculative. 
Regardless, our data clearly demonstrates the ability of sucrose in the diet to elicit metabolic 





public health. The role of O-GlcNAcylation in these changes remains to be seen. It is important 
to note that O-GlcNAcylation is dynamic and we as researchers have only cracked the surface of 
protein regulation by O-GlcNAcylation. A major limitation to this body of research is the 
difficulty in analyzing proteins for the O-GlcNAcylate. Further complicating the analysis is the 
simplicity of the pathway components. Because the pathway only utilizes two enzymes for the 
addition and removal of the O-GlcNAcylate manipulation of the enzymes by different methods 
of inhibition would result in global changes rather than protein specific changes. Manipulation of 
kinases is commonly used to characterize phosphorylated proteins; such methods would not be 
effective in this field.  
In conclusion, effective and reproducible techniques need to be established for O-
GlcNAc research to continue to grow. Further, our dietary data suggests the need for better 
characterization of the long-term effects of a high sucrose diet both in regard to continual use as 
well as seceded use. Growth in both areas of research would support the current need for 

































Illustration 1 Acute Effects of Leptin 
Pictured above is the leptin signaling pathway within a POMC neuron of the ARC. The acute effects of leptin are 



















Pictured above are the leptin receptor isoforms.  Through alternative slicing the gene ObR expresses six functionally 
distinct receptors. (Marroqui et al., 2012) 
 










Illustration 3 Leptin Signaling 
Pictured above is the signal transduction pathway of leptin signaling in the hypothalamus to regulate Pre-
opiomelanocortin (POMC) and Agouti Related Protein (AGRP) expression. This diagram specifically illustrates the 
transcriptional competition between STAT3 and FoxO1 in leptin sensitive tissue. (Park & Ahima, 2014) 
 






Illustration 4 Hexosamine Pathway 
Pictured above is the Hexosamine biosynthesis pathway. Through a series of enzymatic reactions, the 
biosynthesis pathway converts glucose into the high energy substrate UDP-GlcNAc. Enzymes OGT and 
OGA can modify proteins with UDP-GlcNAc by adding and removing, respectively. (Gronning-Wang, 












Illustration 5 OGT and OGA Isoforms 
Pictured above are the various isoforms of OGT and OGA and their respective contributions to cell O-
GlcNAcylation. A) Three isoforms of OGT differentiated by their N terminal repeats. B) Two OGA isoforms 













Illustration 6 Protocol for Modeling Diet Induced Leptin Resistance 





















Pictured above is the process through which the hypothalamus can be macrodissected using only a razor blade. 







Teklad Global 18% Protein Rodent Diet 
      
Energy Density kcal/g 3.1 
Calories from Protein % 24 
Calories from Fat % 18 
Calories from Carbohydrate % 58 
Ingredients (in descending order of inclusion)- Ground wheat, ground corn, wheat 
middlings, dehulled soybean meal, corn gluten meal, soybean oil, calcium 
carbonate, dicalcium phosphate, brewers dried yeast, iodized salt, L- lysine, DL-
methionine, choline chloride, kaolin, magnesium oxide, vitamin E acetate, 
menadione sodium bisulfite complex (source of vitamin K activity), manganous 
oxide, ferrous sulfate, zinc oxide, niacin, calcium pantothenate, copper sulfate, 
pyridoxine hydrochloride, riboflavin, thiamin mononitrate, vitamin A acetate, 
calcium iodate, vitamin B12 supplement, folic acid, biotin, vitamin D3 supplement, 
cobalt carbonate.  
 




























(n=26) 313.9 ±2.9 523.7 ±9.5 178.0 ±7.2 19.9% 
Sucrose 
(n=21) 318.4 ±2.7 531.7 ±11.7 182.7 ±9.5 19.9% 
 


































Presented in Table 1 are group mean initial body weights (g) (p=0.2629), final mean body weight  
(p=0.5933) and mean body weight change from day 1 to day 42 (p=0.6891) Percent fat mass are 

















































Figure 1 Average Weekly Body Weight 
Data are average weekly body weight in grams (g) of control and sucrose groups.  Effect of time on all 
















































Average weight change from overnight fast of control and sucrose fed rats ± SEM (p= 0.2948). 













































































































































Serum circulating factors from truncal blood (n=16) ± SEM (* denotes significant data p<0.05) A. Serum LDL (p=0.8550) B. 








































































Serum circulating factors from truncal blood (n=16) ± SEM (* denotes significant data p<0.05) A. Serum leptin (p=0.0362) 










































































Leptin vs FTL Ratio
A 
B 
Correlations between Fat:Lean Mass and circulating factors (n=32)were examined A. Serum triglycerides (p=0.0029) 





























































The correlation between serum cholesterol and serum HDL in both treatment groups (n=16) (p=0.045925) revealed that 





























































































































































































A.Representative blot of O-GlcNAc  in hypothalamus of both groups of rats. Standard and Total Protein levels were used to 


















Illustrated above are three models of insulin sensitivity in 
the liver. A. Normal insulin sensitive level with normal 
glucose and triglyceride(TG) levels B. Diabetic selective 
insulin resistant liver with elevated glucose and TG levels 
C. LIRKO mouse complete insulin resistant liver with 
elevated glucose but not TG     







Cannulation Verification and Leptin Injection 
Ventricular cannulation using stereotaxic equipment is very precise; however, the 
cannula placement must be verified for accuracy by some sort of measure. A common method is 
to employ an angiotensin II challenge followed by measuring water intake immediately post 
injection. Polydipsia following the injection indicates an appropriate placement. Typically, 1 in 
10 animals fail this challenge. However, in this experiment fewer than half of the rats passed the 
angiotensin II challenge. Further, among those who met the criterion, by consuming more than 3 
mL in an hour, several measurements were omitted due to water bottle leakage (see Figure 11-
A). For this reason, a test at the molecular level was used as a backup verification procedure. 
STAT3 phosphorylation at the tyrosine 705 residue is a known response to leptin signaling and 
was previously shown to be unaffected by a high sucrose diet.(R. B. Harris & Apolzan, 2015) 
However, analyses of pSTAT3 (Y705) data measured in the Sucrose and Control groups show 
no significant increase in pSTAT3 (Y705) in leptin injected rats (see Figure 12-A). The mixed 
and in some case conflicting, results of cannula placement make hypothalamic protein analysis 
difficult to analyze and interpret. For these reasons, the data are interpreted by treatment group 
without including the ICV injection as a variable. This Appendix summarizes the results of the 
analyses that were performed on all of the rats of both the Sucrose and Control groups, all the 
while fully acknowledging that only dietary treatments could be used for inferences about the 






Hypothalamic Protein Quantitation 
Methods 
Right hypothalamic tissue was used to extract protein using the complete tris lysis buffer 
(R60TX) by Meso Scale Discovery (Rockville, MD) at ratio of 100 ul buffer to 10 mg tissue. 
Tissue was homogenized by passing it through an 18 gauge needle, followed by sonication. 
Homogenates were incubated on ice followed by centrifugation. Supernatant was collected and 
frozen at -80°C. Immunoassay analysis for STAT3 and AKT/phosphorylated AKT (pAKT) were 
completed following Meso Scale Discovery’s protocol for pSTAT3 (Y705) (cat K150SVD) and 
AKT/pAKT (cat K15100D), respectively. To analyze FoxO1, lysates were diluted to within 
range of the Signalway Antibody LLC (College Park, MD) Rat FoxO1 ELISA kit (cat EK2219). 
Of these data only 12 samples were sufficiently replicated or within range (Control n=6 Sucrose 
n=6). 
Immunoassay data 
No significant difference between control fed and sucrose fed PI3K pathway proteins in 
hypothalamic tissue were observed. Hypothalamic AKT levels were virtually identical between 
Control at 220680.8 signal units and Sucrose group at 221569.1 signal units (see Figure 13-A i).  
Similarly, no differences between group pAKT and FoxO1 measures were observed, see Figure 
13-A ii and 14-A respectively. Interestingly, there was no significant correlation between 
pSTAT3 and pAKT, as increased pSTAT3 would indicate activation of the PI3K pathway 
thereby increasing pAKT. The lack of correlative data may be due to high variability at basal 
levels as leptin is not the only ligand that regulates PI3K signaling. However, we predict a bolus 







In order to analyze O-GlcNAcylation of proteins, enrichment prior to mass spectrometry 
analysis was required. While the components required to enrich O-GlcNAcylation are 
commercially available, the process of enrichment is extremely complicated and failure rates are 
very high. The levels of O-GlcNAc in complex protein samples are usually so low in comparison 
to other components that the glycosylate is lost during analysis. In conjunction with previous 
research, our analysis of two unenriched hypothalamic samples, one control fed, and one sucrose 
fed, displayed only a few sites of O-GlcNAcylation under higher energy collisional dissociation 
(HCD). However, one modified site stood out among the rest. Prolow-density lipoprotein 
receptor-related protein 1 isoform X1 (LRP-1) was shown to be O-GlcNAcylated at the 
Threonine 1808 residue (AtALAImGDK; Tryptic peptide range 1807-1816) in both samples at 
different sample sizes. Further, no reference of O-GlcNAcylation at the threonine residue of 
LRP-1 has been found.  
LRP-1 is a cell surface receptor, expressed ubiquitously but highly expressed in central 
tissue. Without further analysis the implication of O-GlcNAcylation of LRP-1 cannot be 
determined. But these results suggest LRP-1 may be regulated by O-GlcNAcylation. As a major 
part of lipid metabolism, LRP-1 is an important component of energy homeostasis. Deletion of 
central LRP-1 has been shown to increase intake and reduce energy expenditure, resulting in 
obesity. Effects on energy homeostasis may stem from LRP-1 co-expression in AGRP neurons 
which stimulate hunger.(Q. Liu et al., 2011) Further, LRP-1 is not expressed in POMC neurons 
which stimulate satiety. Previous reports demonstrated O-GlcNAcylation of proteins in AGRP 
neurons is highest during fasting states rather than fed states.(Y. Liu et al., 2012) As AGRP 





discovery of O-GlcNAcylated LRP-1 in both sample lysates is not surprising. Further, LRP-1 has 
been shown to bind directly to the leptin receptor complex and is required for phosphorylation of 
the receptor and there by STAT3 phosphorylation.(Q. Liu et al., 2011)  
LRP-1 was not the protein of interest during this study so an enrichment protocol needs 
to be developed. Future directions for LRP-1 O-GlcNAcylation include more replicates, 
localizing the modification to AGRP neurons and effects of feeding state on the modification. 
An enrichment protocol was adopted by combining Hart and Ma enrichment protocol with the 
simplified click reaction developed by Hseih-Wilson (see Trypsin digestion and Enrichment 
sections below). Initial trials used lysate with the intention to monitor the reactions via various 
assays. However, few assays were available and were not definitive. These reactions need to be 
monitored via mass spectrometry. Complex samples are a poor choice for monitoring reactions.   
As a result, a protein control, alpha-crystallin, was used. Initial tagging via enzymatic addition of 
GalNAz was monitored via mass spectrometry but the protocol failed to successfully complete 
the reaction.   
Future development of the O-GlcNAc enrichment should begin with a control peptide. 
Control O-GlcNAcylated peptides can be difficult to find as they are available as a custom order 
and are not commonly produced by peptide synthesizing companies. However, the peptide is 
essential as the purified peptide reduces possible errors and variability. For example, the peptide 
does not undergo trypsin digestion and can have known O-GlcNAcylation sites as well as 
controlled levels of O-GlcNAcylation by mixing the positive control peptide with its negative 
control counterpart. For example, alpha-crystallin has known O-GlcNAcylation sites and is 
known to be O-GlcNAcylated about 20% at all times. However, the variability in O-








Lysate undergoing enrichment was trypsin digested using Trypsin Gold by Promega 
(Madison, WI). Briefly, lysate was thawed and precipitated with -20°C chilled acetone and 
incubated for 1 hour at -80°C. The precipitate was pelleted, washed with chilled acetone and 
dried. The pellet was then dissolved in resuspension buffer (8 M urea, 50 mM NH4HCO3, 10 
mM Dithiothreitol) at 37°C for 30 minutes. Samples were then reduced by adding 500 mM 
iodoacetamide to a final concentration of 30 mM and incubated at room temperature for 30 
minutes in the dark. The reduction was quenched with the addition of quenching buffer (50 mM 
NH4HCO3, 10 mM Dithiothreitol) and incubation at 37°C for 30 minutes. Samples were then 
diluted with 50 mM NH4HCO3 to reduce urea concentration to ~1M urea. Trypsin was added at 
1 ug trypsin/50 ug protein and incubated overnight at 37°C. Samples were then desalted on 
SMMV18 column (Nest Group, Southborough, MA) and dried before enrichment. 
 
Enrichment 
Digested samples underwent enzymatic tagging using Thermo-Fisher’s Click-It system, 
which conjugates an azide analogue, O-linked N-azidoacetylgalactosamine tetraacylated (O-
GalNAz), to O-GlcNAc. Briefly, dried peptides were solubilized in 10 mM HEPES pH 7.9. The 
enzymatic reaction was set up by adding MnCl2 and substrate UDP-GalNAz followed by mixing. 
The enzyme Gal-T1 was added to samples in addition to PNGase and CIP subsequently mixed 
and incubated overnight at 4°C. Finally, samples were desalted using SMMV18 column (Nest 





via click chemistry reaction with alkyne-dde-biotin. Dried peptides were resuspended in 1x PBS 
before adding copper-click chemistry reagents. Samples were prepared with 2.5 mM alkyne-dde-
biotin and 100 mM THPTA. The reaction was initiated by the addition of 20 mM CuSO4 and 300 
mM sodium ascorbate. The reaction was incubated for 1 hour at room temperature protected 
from light. Excess alkyne-dde-biotin was removed using SCX column (Nest Group, 
Southborough, MA). Biotinylated peptides are collected using Neutravidin Agarose (Thermo 
Fisher, Waltham, MA). Briefly, Neutravidin agarose was prepared in microspin tubes and 
washed with PBS. Samples were added to column and incubated for 1 hour at room temperature. 
Columns were washed with PBS to remove unbound protein. Peptides were cleaved from the 
column by incubating column with 2% hydrazine monohydrate at room temperature for 1 hour. 
Samples were spun to elute peptides and washed with PBS to remove remaining peptides. 























































Figure 11-A Angiotensin II Challenge 
Water intake in 1 hour after ICV angiotensin II administration grouped by experimental units who completed 
the protocol without complications and by experimental units who completed the protocol with complications. 





































Hypothalmic pSTAT3 Y705 
Control Leptin Control Saline Sucrose Leptin Sucrose Saline
Figure 12-A Hypothalamic STAT3 Phosphorylation 
Right hypothalamic pSTAT3 Y705 scatter plot grouped by treatment group. Blue line demonstrates average 






































































i. Right Hypothalamic pAKT Serine 473 by treatment group (n=16) (p=0.7493) ii. Right 
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